Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-10

Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating transplantation of human umbilical cord mesenchymal stem cells for articular cartilage defects and osteoarthritis; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Cartilage Diseases, Osteoarthritis | Phase 1 | Status: COMPLETED